Pro Medicus
$156.38Change from previous close: −2.92%Absolute change: −$4.71
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- $16.34B
- Enterprise value
- $16.09B
- P/E (trailing 12 months)
- 61.8
- Forward P/E
- 68.5
- PEG
- 2.67
- Price/book
- 36.2
- Price/sales
- 62.4
- EV/EBITDA
- 81.9
- EV/revenue
- 61.5
Profitability and growth
- Gross margin
- 99.8%
- Operating margin
- 77.0%
- Net margin
- 101.4%
- ROE
- 75.0%
- ROA
- 25.8%
- Revenue growth (year over year)
- 18.2%
- Earnings growth (year over year)
- 48.4%
Financial health
- Total cash
- $252.28M
- Total debt
- $2.23M
- Debt/equity
- 0.00
- Current ratio
- 6.85
- Quick ratio
- 6.75
Dividends
- Annual dividend per share
- $0.69
- Dividend yield
- 0.4%
- Payout ratio
- 24.5%
- Ex-dividend date
- September 7, 2026
Analysts and estimates
- Average price target
- $202.47
- Median price target
- $222.00
- High price target
- $250.00
- Low price target
- $60.00
- Analysts with a price target
- 15
- Consensus
- Buy
- Forward EPS
- $2.28
- EPS estimate, current year
- $1.83
Shares and trading
- Beta
- 0.58
- Average volume
- 234.27K
- Shares outstanding
- 104.47M
- Float
- 53.32M
- Institutional ownership
- 25.4%
- Insider ownership
- 49.0%